Assembly Biosciences (NASDAQ:ASMB) Announces Quarterly Earnings Results, Beats Estimates By $2.99 EPS
Assembly Biosciences (NASDAQ:ASMB - Get Free Report) released its quarterly earnings data on Thursday. The biopharmaceutical company reported $2.48 EPS for the quarter, topping analysts' consensus estimates of ($0.51) by $2.99. The company had revenue of $42.47 million for the quarter, compared to...